MERCK & CO., INC.
Collaborative Engagement on Access to Medicine and SDG3
62 members
A man walks into a shoe store, and tries on a pair of shoes.
Type
Engagement or initiative
Status
Seeking support
Deadline
31 December 2025
Contact
Collaboration details
Lorem Ipsum has been the industry standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.
Engagement focus
Takeda Pharmaceutical Company Limited
Sanofi Aventis
PFIZER INC.
NOVO NORDISK A/S
Novartis AG
Merck KGaA
JOHNSON & JOHNSON
GlaxoSmithKline PLC
GILEAD SCIENCES, INC.
ELI LILLY AND COMPANY
Eisai Co., Ltd.
DAIICHI SANKYO COMPANY, LIMITED
BRISTOL-MYERS SQUIBB COMPANY
BAYER CORPORATION
ASTRAZENECA PLC
Astellas Pharma Inc.
ABBVIE INC.
Roche Holding AG
Created on
ESG theme
- Social
ESG sub-theme
- Human rights
- Public health
Sector
- Health Care
Sustainable Development Goal
- 3 - Good health & well-being
Geography
- Global
Asset class
All